Welcome to RECONNECT Fragile X Study Website.
Currently there are no approved therapies for the treatment of Fragile X syndrome, a rare genetic disorder.
This research study is currently enrolling individuals ages 3 to 22 years of age with Fragile X syndrome.
To see if someone you love may be able to participate, please apply to learn more.
![Apply to participate in Zynerba Fragile X Syndrome clinical trial in UK](https://fragilexhelp.co.uk/wp-content/uploads/2023/08/Zynerba_Flyer_UK_Zynerba-ZYN2-CL-033_28AUG2023_AR-PM-WEBSITE.jpg)
Learn more about a clinical trial evaluating an investigational treatment to see if it helps behavioural issues related to Fragile X syndrome.
Qualified participants are:
- Between 3 and 22 years of age
- Diagnosed via genetic testing, with Fragile X syndrome
- In generally good health